Clinical Trials Browser

Central Nervous System Neoplasms × Bevacizumab × 90 days × Clear all

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Phase EARLY_PHASE1 Withdrawn

Central Nervous System Neoplasms